Novonesis Upgrades FY26 Outlook

MT Newswires · 2d ago
12:29 AM EDT, 08/20/2026 (MT Newswires) -- Novonesis (NSIS-B.CO) on Wednesday raised its organic sales growth guidance for 2026. The Danish biosolutions company now forecasts organic sales growth in the range of 7% to 8%, against the previously expected growth between 5% and 7%.